BTCS Inc
BTCS
Digihost Technology
DGHI
CATHEDRA BITCOIN INC
CBTTF
Bakkt Holdings
BKKT
Abits
ABTS
CytomX Therapeutics, Inc. is a clinical-stage, oncology-focused biopharmaceutical company, which engages in the development of conditionally activated, biologics localized to the tumor microenvironment. The company was founded by Frederick W. Gluck and Nancy E. Stagliano in September 2010 and is headquartered in South San Francisco, CA.